Got 90 seconds? Then listen to CEO and Managing Director, Tim Oldham, tell us about their company strategy and upcoming newsflow.

AdAlta Limited (ASX:1AD) is a clinical stage biotechnology company using its i-body platform to discover and develop next generation protein therapeutics addressing drug targets that are challenging for other technologies.

We gave CEO and Managing Director Tim Oldham 90 seconds to tell us more about the company.

Have a good idea for our next 90 Seconds With segment? Email us at tv@stockhead.com.au.